Remyelination varies between and within lesions in multiple sclerosis following bexarotene. (2022)
Attributed to:
Dementias Platform UK Stem Cell Partnership
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.89765
Publication URI: https://www.repository.cam.ac.uk/handle/1810/342345
Type: Journal Article/Review